Skip to main content
SpringerLink
Log in

The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders

  • Chapter
  • First Online:
Science of Ashwagandha: Preventive and Therapeutic Potentials

  • 1331 Accesses

Abstract

Bipolar Disorder is a mood disorder that can be quite severe for subgroups of patients, and often such patients manifest deficits in attention, concentration, memory, and executive functions that persist even when they are relatively well. Cognitive concerns can impair daily life functioning and impact employment, education, and interpersonal relationships. Main line treatments for bipolar disorder typically do not address cognitive impairments, and some treatments may actually worsen cognitive deficits. Treatment development for cognitive impairments in bipolar disorder is truly in its infancy; extracts of Ashwagandha (Withania somnifera) may hold promise as a potential treatment option. The bioactive constituents of Ashwagandha, including withanolides, indosides, Withaferin A, and others, possess anti-inflammatory-immunomodulatory, anti-oxidant, cortisol lowering, anti-stress, pro-cholinergic, anti-glutamatergic and neuroprotective properties, the very processes that are thought to underlie cognitive impairments not only in in bipolar disorder but also in other psychiatric disorders like schizophrenia and major depression. This chapter reviews this in detail and highlights the preliminary randomized controlled study assessing an extract of Ashwagandha for improving cognition in bipolar disorder. The chapter also explores the potential role of Ashwagandha extracts in the treatment of other neurocognitive disorders, and it concludes by summarizing additional future research needed to realize the potential of this ancient medicinal plant for the treatment of human ailments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agarwal R, Diwanay S, Patki P, Patwardhan B (1999) Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 67:27–35

    Article  CAS  PubMed  Google Scholar 

  • Ahmed ME, Javed H, Khan MM, Vaibhav K, Ahmad A, Khan A, Tabassum R, Islam F, Safhi MM, Islam F (2013) Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment. Protoplasma 250:1067–1078

    Article  CAS  PubMed  Google Scholar 

  • Akintola AA, Jansen SW, van Bodegom D, van der Grond J, Westendorp RG, de Craen AJ, van Heemst D (2015) Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci 11:7–150

    Google Scholar 

  • Alonso J, Petukhova M, Vilagut G, Chatterji S, Heeringa S, Üstün TB, Alhamzawi AO, Viana MC, Angermeyer M, Bromet E, Bruffaerts R, de Girolamo G, Florescu S, Gureje O, Haro JM, Hinkov H, Hu CY, Karam EG, Kovess V, Levinson D, Medina-Mora ME, Nakamura Y, Ormel J, Posada-Villa J, Sagar R, Scott KM, Tsang A, Williams DR, Kessler RC (2011) Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry 16:1234–1246

    Article  CAS  PubMed  Google Scholar 

  • Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J (2004) Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 56:560–569

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5). American Psychiatric Publishing, Washington, DC

    Google Scholar 

  • Anbalagan K, Sadique J (1981) Influence of an Indian medicine (Ashwagandha) on acute-phase reactants in inflammation. Indian J Exp Biol 19:245–249

    CAS  PubMed  Google Scholar 

  • Anbalagan K, Sadique J (1985) Withania somnifera (ashwagandha), a rejuvenating herbal drug which controls a-2 macroglobulin synthesis during inflammation. Int J Crude Drug Res 23:177–183

    Article  Google Scholar 

  • Andallu B, Radhika B (2000) Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol 38:607–609

    CAS  PubMed  Google Scholar 

  • Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R (2000) A double-blind, placebo-controlled evaluation of the anxiolytic efficacy of an ethanolic extract of Withania Somnifera. Indian J Psychiatry 42:295–301

    CAS  PubMed  PubMed Central  Google Scholar 

  • Atre-Vaidya N, Taylor MA, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F (1998) Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry Neuropyschol Behav Neurol 11:120–126

    CAS  Google Scholar 

  • Auddy B, Hazra J, Mitra A, Abedon B, Ghosal S (2008) A standardized Withania somnifera Extract significantly reduces stress-related parameters in chronically stressed humans: A double-blind, randomized, placebo-controlled study. JANA 11:51–57

    Google Scholar 

  • Bauer M, Glenn T, Pilhatsch M, Pfennig A, Whybrow PC (2014a) Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disord 16:58–71

    Article  PubMed  Google Scholar 

  • Bauer IE, Pascoe MC, Wollenhaupt-Aguiar B, Kapczinski F, Soares JC (2014b) Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res 56:18–27

    Article  PubMed  PubMed Central  Google Scholar 

  • Bearden CE, Shih VH, Green MF, Gitlin M, Sokolski KN, Levander E, Marusak S, Hammen C, Sugar CA, Altshuler LL (2011) The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: A prospective study. Bipolar Disord 13:323–333

    Article  PubMed  PubMed Central  Google Scholar 

  • Begum V, Sadique J (1988) Long term effect of herbal drug Withania somnifera on adjuvant induced arthritis in rats. Indian J Exp Biol 26:877–882

    CAS  PubMed  Google Scholar 

  • Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetylcysteine for depressive symptoms in bipolar disorder – a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468–475

    Article  CAS  PubMed  Google Scholar 

  • Besedovsky H, del Rey A, Sorkin E, Da Prada M, Burri R, Honegger C (1983) The immune response evokes changes in brain noradrenergic neurons. Science 221:564–566

    Article  CAS  PubMed  Google Scholar 

  • Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: An experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75:547–555

    Article  CAS  PubMed  Google Scholar 

  • Brar JS, Chengappa KNR (2011) Does one shoe fill all? The Randomized Controlled Clinical Trial (RCT) as a model for assessing the efficacy or effectiveness of whole systems Ayurveda or other Traditional Medicine (TM) treatments. J Ayurveda Integr Med 2:91–93

    Article  PubMed  PubMed Central  Google Scholar 

  • Brown NC, Andreazza AC, Young LT (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Research 218:61–68

    Article  CAS  PubMed  Google Scholar 

  • Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK (2012) A Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: Targeting cognitive dysfunction. J Clin Psychiatry 73:103–112

    Article  CAS  PubMed  Google Scholar 

  • Cannon WB (1932) The wisdom of the body. WW Norton, New York

    Google Scholar 

  • Chandrasekhar K, Kapoor J, Anishetty S (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 34:255–262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42:484–491

    Article  CAS  PubMed  Google Scholar 

  • Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R (2013) Randomized placebo-controlled adjunctive study of an extract of Withania Somnifera for Cognitive Dysfunction in Bipolar Disorder. J Clin Psychiatry 74:1076–1083

    Article  PubMed  Google Scholar 

  • Chopra A, Lavin P, Patwardhan B, Chitre D (2000) Randomized Double-blind trial of an Ayurvedic Plant derived formulation for Treatment of Rheumatoid arthritis. Journal of Rheumatology 27:1365–1372

    CAS  PubMed  Google Scholar 

  • Chopra A, Lavin P, Patwardhan B, Chitre D (2004) A 32-week randomized, placebo-controlled clinical evaluation of RA-11, and Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 10:236–245

    Article  PubMed  Google Scholar 

  • Choudhary MI, Yousuf S, Nawaz SA, Ahmed S, Atta-ur-Rahman (2004) Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo) 52:1358–1361

    Article  CAS  Google Scholar 

  • Choudhary D, Bhattacharyya S, Joshi K (2017) Body weight management in adults under chronic stress through treatment with Ashwagandha root extract: A double-blind, randomized, placebo-controlled trial. J Evid Based Complementary and Altern Med 22:96–106

    Article  Google Scholar 

  • Chrousos GP (1995) The Hypothalamic-Pituitary-Adrenal Axis and Immune-Mediated Inflammation. N Engl J Med 332:1351–1363

    Article  CAS  PubMed  Google Scholar 

  • Clark L, Goodwin G (2008) Attentional and Executive Functioning in Bipolar Disorder. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 23–47

    Google Scholar 

  • Clark L, Iverson SD, Goodwin GM (2001) A neuropsychological investigation of the prefrontal cortex involvement in acute mania. Am J Psychiatry 158:1605–1611

    Article  CAS  PubMed  Google Scholar 

  • Clark L, Sarna A, Goodwin GM (2005) Impairment of executive function but not memory in first degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression. Am J Psychiatry 162:1980–1982

    Article  PubMed  Google Scholar 

  • Coogan AN, Wyse CA (2008) Neuroimmunology of the circadian clock. Brain Res 1232:104–112

    Article  CAS  PubMed  Google Scholar 

  • Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, Seely D (2009) Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One 4:e6628

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 9:46–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dar NJ, Hamid A, Ahmed M (2015) Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell Mol Life Sci 72:4445–4460

    Article  CAS  PubMed  Google Scholar 

  • Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M (2015) C-Reactive Protein Alterations in Bipolar Disorder: A meta-analysis. J Clin Psychiatry 76:142–150

    Article  PubMed  Google Scholar 

  • Demant KM, Vinberg M, Kessing LV, Miskowiak KW (2015) Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: Results of a randomised controlled trial. PLoS One 10:e0127955

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dickerson FB, Boronow JJ, Stallings CR, Origoni AE, Cole S, Yolken RH (2004) Association between cognitive functioning and employment status of persons with bipolar disorder. Psychol Serv 55:54–58

    Article  Google Scholar 

  • Dupont RM, Jernigan TL, Butters N, Delis D, Hesselink JR, Heindel W, Gillin JC (1990) Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry 47:55–59

    Article  CAS  PubMed  Google Scholar 

  • Durg S, Dhadde SB, Vandal R, Shivakumar BS, Charan CS (2015) Withania somnifera (Ashwagandha) in neurobehavioral disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J Pharmacy Pharmacol 67:879–899

    Article  CAS  Google Scholar 

  • Elgamal L, Sokolowska M, MacQueen G (2008) Memory deficits associated with Bipolar Disorder. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp p49–p67

    Google Scholar 

  • Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH (2004) Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report. Bipolar Disord 6:319–322

    Article  PubMed  Google Scholar 

  • Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH (2005) The Maudsley bipolar disorder project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 58:859–864

    Article  PubMed  Google Scholar 

  • Frank E, Swartz HA, Kupfer DJ (2000) Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 48:593–604

    Article  CAS  PubMed  Google Scholar 

  • Gajarmal AA, Shende MB (2015) A clinical evaluation of antistress activity of Ashwagandha (Withania somnifera Dunal) on employees experiencing mental stress at work place. Int J Ayur Pharma Res 3:37–45

    Google Scholar 

  • Ganguli R, Brar JS, Rabin BS (1994) Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv Rev Psychiatry 2:70–83

    Article  CAS  PubMed  Google Scholar 

  • Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin BS (1995) Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. Arch Gen Psychiatry 52:668–672

    Article  CAS  PubMed  Google Scholar 

  • Gannon JM, Forrest PE, Chengappa KNR (2014) Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. J Ayurveda Integr Med 5:241–245

    Article  PubMed  PubMed Central  Google Scholar 

  • Gershon S, Chengappa KNR (2009) Contemporary diagnosis and management of bipolar disorders. Handbooks in Health Care Company, Newtown

    Google Scholar 

  • Ghosal S, Kaur R, Srivatsava RS (1988) Sitoindosides IX and X, two new withanolide glycosides from Withania Somnifera. Indian J Nat Prod 4:12–13

    CAS  Google Scholar 

  • Glahn DC, Burdick KE, Bearden CE (2008) The Endophenotye concept. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 69–88

    Google Scholar 

  • Goldberg JF (2008) Adverse cognitive effects of psychotropic medications. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 137–158

    Google Scholar 

  • Goldberg JF, Burdick KE (eds) (2008) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing, Inc. Arlington

    Google Scholar 

  • Goldberg JF, Chengappa KNR (2009) Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disord 11(Suppl 2):123–137

    Article  PubMed  Google Scholar 

  • Goodwin FK, Jamison KR (2007) Manic depressive illness, 2nd edn. Oxford University Press, New York

    Google Scholar 

  • Gorelick J, Rosenberg R, Smotrich A, Hanuš L, Bernstein N (2015) Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry 116:283–289

    Article  CAS  PubMed  Google Scholar 

  • Grande I, Berk M, Birmaher B, Vieta E (2015) Bipolar Disorder. The Lancet 387:1561–1572

    Article  Google Scholar 

  • Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321–330

    Article  CAS  PubMed  Google Scholar 

  • Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D (2012) Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn 29:651–562

    Article  CAS  PubMed  Google Scholar 

  • Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002) Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psych 59:521–529

    Article  CAS  Google Scholar 

  • Hibberd C, Yau JLW, Seckyl JR (2000) Glucocorticoids and the ageing hippocampus. J Anat 197:553–562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jain S, Shukla SD, Sharma K, Bhatnagar M (2001) Neuroprotective Effects of Withania somnifera Dunn in Hippocampal Sub-regions of Female Albino Rat. Phytother Res 15:544–548

    Article  CAS  PubMed  Google Scholar 

  • Jayaprakasam B, Nair MG (2003) Cyclooxygenase-2 enzyme inhibitory withanolides from Withania Somnifera leaves. Tetrahedron 59:841–849

    Article  CAS  Google Scholar 

  • Joyashiki E, Matsuya Y, Tohda C (2011) Sominone improves memory impairments and increases axonal density in Alzheimer’s disease model mice, 5XFAD. Int J Neurosci 121:181–190

    Article  CAS  PubMed  Google Scholar 

  • Kataria H, Wadhwa R, Kaul SC, Kaur G (2012) Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One 7:e37080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60:1020–1022

    Article  CAS  PubMed  Google Scholar 

  • Khan ZA, Ghosh AR (2010) Possible nitric oxide modulation in protective effects of withaferin A against stress induced neurobehavioral changes. J Medicinal Plants Res 4:490–495

    CAS  Google Scholar 

  • Khan B, Ahmad SF, Bani S, Kaul A, Suri KA, Satti NK, Athar M, Qazi GN (2006) Augmentation and proliferation of T lymphocytes and Th-1cytokines by Withania somnifera in stressed mice. Int Immunopharmacol 6:1394–1403

    Article  CAS  PubMed  Google Scholar 

  • Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R, Thakur MK (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain derived cells. PloS One 6:e27265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kour K, Pandey A, Suri KA, Satti NK, Gupta KK, Bani S (2009) Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A. Intl Immunopharmacol 9:1137–1144

    Article  CAS  Google Scholar 

  • Kronfol Z, Remick DG (2000) Cytokines and the brain: Implications for clinical psychiatry. Am J Psychiatry 157:683–694

    Article  CAS  PubMed  Google Scholar 

  • Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961–971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuboyama T, Tohda C, Komatsu K (2006) Withanoside IV and its active metabolite, sominone, attenuate Aβ(25-35)-induced neurodegeneration. Eur J Neurosci 23:1417–1426

    Article  PubMed  Google Scholar 

  • Kuboyama T, Tohda C, Komatsu K (2014) Effects of Ashwagandha (Roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull 37:892–897

    Article  CAS  PubMed  Google Scholar 

  • Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Progress in Neuro-Psychopharmacol Biol Psychiatry 32:1093–1105

    Article  CAS  Google Scholar 

  • Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double blind, placebo-controlled, crossover study. J Ethno Pharmacol 33:91–95

    Article  CAS  Google Scholar 

  • Kumar P, Kumar A (2008) Effects of root extract of Withania somnifera in 3-Nitropropionic acid-induced cognitive dysfunction and oxidative damage in rats. Int J Health Res 1:139–149

    Google Scholar 

  • Kumar P, Kumar A (2009) Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington’s disease. J Medicinal Food 12:591–600

    Article  CAS  Google Scholar 

  • Kurapati KR, Atluri VS, Samikkannu T, Nair MP (2013) Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e77624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lupien SJ, Gillin CJ, Hauger RL (1999) Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose–response study in humans. Behav Neurosci 113:420–430

    Article  CAS  PubMed  Google Scholar 

  • Malhi GM, Cahill CM, Mitchell P (2008) Impact of Mood, Anxiety, and Psychotic Symptoms on Cognition in Patients with Bipolar Disorder. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 89–111

    Google Scholar 

  • Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN (2007) A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80:1525–1538

    Article  CAS  PubMed  Google Scholar 

  • Mann-Wrobel MC, Carreno JT, Dickinson D (2011) Meta-analyses of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord 13:334–342

    Article  PubMed  Google Scholar 

  • Martínez-Arán A, Penadés R, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gastó C (2002) Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 71:39–46

    Article  PubMed  Google Scholar 

  • Martínez-Arán A, Vieta E, Colom F, Torrent C, Sánchez-Moreno J, Reinares M, Benabarre A, Goikolea JM, Brugué E, Daban C, Salamero M (2004a) Cognitive Impairment in euthymic bipolar patients: implications for clinical and functional outcomes. Bipolar Disord 6:224–232

    Article  PubMed  Google Scholar 

  • Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M (2004b) Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 161:262–270

    Article  PubMed  Google Scholar 

  • McIntosh AM, Harrison LK, Forrester K, Lawrie SM, Johnstone EC (2005) Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry 186:378–385

    Article  PubMed  Google Scholar 

  • Michael N, Erfurth MN, Ohrmann P, Gossling M, Arrolt V, Heindel W, Pfliederer B (2003) Acute mania is accompanied by elevated levels of glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacol 168:344–346

    Google Scholar 

  • Mikolai J, Erlandsen A, Murison A, Brown KA, Gregory WL, Raman-Caplan P, Zwickey HL (2009) In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes. J Altern Complement Med 15:423–430

    Article  PubMed  Google Scholar 

  • Miller AH (2010) Depression and immunity: a role for T cells? Brain Behav Immun 24:1–8

    Article  CAS  PubMed  Google Scholar 

  • Miller A, Maletic V, Raison C (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732–741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M (2014) Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry 75:1347–1355

    Article  PubMed  Google Scholar 

  • Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176

    Article  CAS  PubMed  Google Scholar 

  • Morrens M, Wezenberg E, Verkes RJ, Hulstijn W, Ruigt GS, Sabbe BG (2007) Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short term administration. J Clin Psychopharmacol 27:15–21

    Article  CAS  PubMed  Google Scholar 

  • Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, Dewitt DL, Holmes D, Sung B, Aggarwal BB, Tsay HS, Nair MG (2009) Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-Kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res 22:987–992

    Article  CAS  Google Scholar 

  • Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotoxicity Res 10:131–148

    Article  CAS  Google Scholar 

  • Müller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Möller HJ, Klauss V, Schwarz MJ, Riedel M (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophrenia Res 121:118–124

    Article  Google Scholar 

  • Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohanakumar KP (2000) Association of L-DOPA with recovery following Ayurveda medication in Parkinson’s disease. J Neurol Sci 176:124–127

    Article  CAS  PubMed  Google Scholar 

  • Naidu PS, Singh A, Kulkarni SK (2006) Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytotherapy Res 20:140–146

    Article  Google Scholar 

  • Nashine K, Srivastava DN, Sahni YP (1995) Role of inflammatory mediators in anti-inflammatory activity of Withania somnifera. Indian Veterinary Medical J 19:286–288

    CAS  Google Scholar 

  • Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Bowden CL, Soares JC (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized placebo-controlled study. Hum Psychopharmacol 23:87–94

    Article  CAS  PubMed  Google Scholar 

  • Özerdem A, Tunca Z, Çımrın D, Hıdıroğlu C, Ergör G (2014) Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Bipolar Disord 16:72–82

    Article  PubMed  CAS  Google Scholar 

  • Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65:395–407

    Article  CAS  PubMed  Google Scholar 

  • Panda S, Kar A (1997) Evidence for Free radical scavenging activity of Ashwagandha root powder in mice. Indian J Physiol Pharmacol 41:424–426

    CAS  PubMed  Google Scholar 

  • Panda S, Kar A (1998) Changes in thyroid hormone concentrations after administration of Ashwagandha root extract to adult male mice. J Pharm Pharmacol 50:1065–1068

    Article  CAS  PubMed  Google Scholar 

  • Panda S, Kar A (1999) Withania somnifera and bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol 67:233–239

    Article  CAS  PubMed  Google Scholar 

  • Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F (2015) Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab 100:4240–4248

    Article  CAS  PubMed  Google Scholar 

  • Resmini E, Santos A, Gómez-Anson B, López-Mourelo O, Pires P, Vives-Gilabert Y, Crespo I, Portella MJ, de Juan-Delago M, Webb SM (2013) Hippocampal dysfunction in cured Cushing’s syndrome patients detected by (1) H-MR-spectroscopy. Clin Endocrinol 79:700–707

    CAS  Google Scholar 

  • Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB (2006) A meta-analyses of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93:105–111

    Article  PubMed  Google Scholar 

  • Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS (2015) Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord 188:149–159

    Article  PubMed  Google Scholar 

  • Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA (1984) Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41:72–80

    Article  CAS  PubMed  Google Scholar 

  • Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr, Weissenburger JE, Crowley GT, Khatami M, Vasavada N (1996) The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57:470–484

    Article  CAS  PubMed  Google Scholar 

  • Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522–524

    Article  CAS  PubMed  Google Scholar 

  • Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Progr Neuropsychopharmacol Biol Psychiatry 29:201–217

    Article  CAS  Google Scholar 

  • Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V (1997) Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic or GABAergic markers in rat brain. Neurochem Int 30:181–190

    Article  CAS  PubMed  Google Scholar 

  • Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V (2012) Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 109:3510–3515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Selye H (1956) The stress of life. McGraw-Hill, New York

    Google Scholar 

  • Singh D, Aggarwal A, Maurya R, Naik S (2007) Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res 10:905–913

    Article  CAS  Google Scholar 

  • Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13:178–184

    PubMed  PubMed Central  Google Scholar 

  • Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE (2001) Elevated cortisol levels in Cushing’s disease are associated with cognitive decrements. Psychosom Med 63:985–993

    Article  CAS  PubMed  Google Scholar 

  • Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB (1999) Omega 3 fatty acids in bipolar disorder: a preliminary, double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407–412

    Article  CAS  PubMed  Google Scholar 

  • Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, Sridhar P, Jayaprakasam B, Nair MG (2006) Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod 12:1790–1792

    Article  CAS  Google Scholar 

  • Szentivanyi A (1989) The discovery of immune-neuroendocrine circuits in the fall of 1951. In: Hadden JW, Masek K, Nistico G (eds) Interactions among central nervous system, neuroendocrine and immune systems. Pythagora Press, Rome-Milan, pp 1–3

    Google Scholar 

  • Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, Young AH (2005) Cognitive Impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 186:32–40

    Article  PubMed  Google Scholar 

  • Tighe SK, Reading SA, Rivkin P, Caffo B, Schweizer B, Pearlson G, Potash JB, Depaulo JR, Bassett SS (2012) Total white matter hyperintensity volume in bipolar disorder patients and their healthy relatives. Bipolar Disord 14:888–893

    Article  PubMed  PubMed Central  Google Scholar 

  • Tohda C, Joyashiki E (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. British J Pharmacol 157:1427–1440

    Article  CAS  Google Scholar 

  • Torrent C, Martínez-Arán A, Daban C, Sánchez-Moreno J, Comes M, Goikolea JM, Salamero M, Vieta E (2006) Cognitive impairment in bipolar II disorder. Br J Psychiatry 189:254–259

    Article  PubMed  Google Scholar 

  • Torres IJ, Boudreau VG, Yatham LN (2007) Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 116(suppl):17–26

    Article  Google Scholar 

  • Torres IJ, DeFreitas CM, Yatham LN (2008) Cognition and functional outcome in bipolar disorder. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 217–234

    Google Scholar 

  • Tremont G, Stern RA (1997) Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment. Psychopharmacol Bull 33:273–280

    CAS  PubMed  Google Scholar 

  • Udayakumar R, Kasthurirengan S, Vasudevan A, Mariashibu TS, Rayan JJ, Choi CW, Ganapathi A, Kim SC (2010) Antioxidant effect of dietary supplement Withania somnifera L. Reduce blood glucose levels in alloxan-induced diabetic rats. Plant Foods Hum Nutr 65:91–98

    Article  CAS  PubMed  Google Scholar 

  • van der Hooft CS, Hoekstra A, Winter A, de Smet PA, Stricker BH (2005) Thyrotoxicosis following the use of Ashwagandha. Ned Tijdschr Geneeskd 149:2637–2638

    PubMed  Google Scholar 

  • Veronese N, Solmi M, Luchini C, Lu RB, Stubbs B, Zaninotto L, Correll CU (2016) Acetylcholinesterase inhibitors and memantine in bipolar disorder: a systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions. J Affect Disord 197:268–280

    Article  CAS  PubMed  Google Scholar 

  • Vieta E, Martinez-Aran A, Goldberg JF (2008) Cognition across the life span. In: Goldberg JF, Burdick KE (eds) Cognitive dysfunction in bipolar disorder. A guide to clinicians. American Psychiatric Publishing Inc, Arlington, pp 235–255

    Google Scholar 

  • Wehr TA, Sack DA, Rosenthal NE (1987) Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 144:201–204

    Article  CAS  PubMed  Google Scholar 

  • Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E (1998) Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 43:822–828

    Article  CAS  PubMed  Google Scholar 

  • Whelan TB, Schteingart DE, Starkman MN, Smith A (1980) Neuropsychological deficits in Cushing’s syndrome. J Nerv Ment Dis 168:753–757

    Article  CAS  PubMed  Google Scholar 

  • Wingo AP, Harvey PD, Baldessarini RJ (2009) Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 11:113–125

    Article  PubMed  Google Scholar 

  • Wingo AP, Baldessarini RJ, Compton MT, Harvey PD (2010) Correlates of recovery of social functioning in type I and II bipolar disorder patients. Psychiatry Res 177:131–134

    Article  PubMed  PubMed Central  Google Scholar 

  • Wirz-Justice A, Bromundt V, Cajochen C (2009) Circadian disruption and psychiatric disorders: the importance of entrainment. Sleep Med Clin 4:273–284

    Article  Google Scholar 

  • Yadav CS, Kumar V, Suke SG, Ahmed RS, Mediratta PK, Banerjee BD (2010) Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera. Indian J Biochem Biophys 47:117–120

    CAS  PubMed  Google Scholar 

  • Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacol (Berl) 145:260–266

    Article  CAS  Google Scholar 

  • Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (2004) Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone in bipolar disorder. Neuropsychopharmacol 29:1538–1545

    Article  CAS  Google Scholar 

  • Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine specific central monoamine alterations induced by IL-1, IL-2 and IL-6. Brain Res 643:40–49

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    K. N. Roy Chengappa & Jessica M. Gannon

  2. Icahn School of Medicine at Mount Sinai (Bronx) Program, James J. Peters VA Medical Center, Bronx, NY, USA

    Luna Acharya

  3. University of Pittsburgh Medical Center – Northwest, Seneca, PA, USA

    Abhishek Rai

Authors
  1. K. N. Roy Chengappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica M. Gannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luna Acharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abhishek Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. N. Roy Chengappa .

Editor information

Editors and Affiliations

  1. DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Biomedical Research Institute, National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Ibaraki, Japan

    Sunil C. Kaul

  2. DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Biomedical Research Institute, National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Ibaraki, Japan

    Renu Wadhwa

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Roy Chengappa, K.N., Gannon, J.M., Acharya, L., Rai, A. (2017). The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders. In: Kaul, S., Wadhwa, R. (eds) Science of Ashwagandha: Preventive and Therapeutic Potentials. Springer, Cham. https://doi.org/10.1007/978-3-319-59192-6_17

Download citation

Publish with us

Policies and ethics

Search

Navigation